View in EDS HTML Full Text PDF Full Text

Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions.

Saved in:
Bibliographic Details
Title: Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions.
Authors: Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., O'Donnell EK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., O'Gorman P; Haematology Department, The Mater Misericordiae University Hospital, Dublin, Ireland., Leypoldt LB; Department of Hematology, Oncology & Bone Marrow Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Laubach J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Gay F; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Leleu X; Department of Hematology, University of Poitiers, CHU & Inserm, Poitiers, France., Facon T; Department of Hematology, University Hospital and INSERM UMR-S1277, Lille, France., Moreau P; Department of Clinical Hematology, University Hospital Hôtel Dieu, Nantes, France., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.; Department of Medicine, University of Korea, Seoul, South Korea., Goldschmidt H; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Mai EK; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Cavo M; Department of Surgical and Medical Sciences, Università di Bologna, Bologna, Italy., Weisel KC; Medical Clinic and Polyclinic II, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Berdeja JG; Multiple Myeloma Research, Tennessee Oncology, Nashville, TN, USA., Orlowski RZ; Departments of Lymphoma and Myeloma, and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beksaç M; Department of Hematology, Istinye University, Ankara, Turkey., Perrot A; Service d'Hématologie, CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Toulouse, France., Mikhael J; Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, USA., Martin T; Division of Hematology-Oncology, University of California, San Francisco, CA, USA.
Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2025 Jul-Aug; Vol. 34 (7-8), pp. 571-589. Date of Electronic Publication: 2025 Jul 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40657944
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Richardson+PG%22">Richardson PG</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22O'Donnell+EK%22">O'Donnell EK</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22O'Gorman+P%22">O'Gorman P</searchLink>; Haematology Department, The Mater Misericordiae University Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Leypoldt+LB%22">Leypoldt LB</searchLink>; Department of Hematology, Oncology & Bone Marrow Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Laubach+J%22">Laubach J</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gay+F%22">Gay F</searchLink>; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; Department of Hematology, University of Poitiers, CHU & Inserm, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Facon+T%22">Facon T</searchLink>; Department of Hematology, University Hospital and INSERM UMR-S1277, Lille, France.<br /><searchLink fieldCode="AU" term="%22Moreau+P%22">Moreau P</searchLink>; Department of Clinical Hematology, University Hospital Hôtel Dieu, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Dimopoulos+MA%22">Dimopoulos MA</searchLink>; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.; Department of Medicine, University of Korea, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Mai+EK%22">Mai EK</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Cavo+M%22">Cavo M</searchLink>; Department of Surgical and Medical Sciences, Università di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Weisel+KC%22">Weisel KC</searchLink>; Medical Clinic and Polyclinic II, University Hospital Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Berdeja+JG%22">Berdeja JG</searchLink>; Multiple Myeloma Research, Tennessee Oncology, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Orlowski+RZ%22">Orlowski RZ</searchLink>; Departments of Lymphoma and Myeloma, and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Beksaç+M%22">Beksaç M</searchLink>; Department of Hematology, Istinye University, Ankara, Turkey.<br /><searchLink fieldCode="AU" term="%22Perrot+A%22">Perrot A</searchLink>; Service d'Hématologie, CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Mikhael+J%22">Mikhael J</searchLink>; Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Martin+T%22">Martin T</searchLink>; Division of Hematology-Oncology, University of California, San Francisco, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229434197%22">Expert opinion on investigational drugs</searchLink> [Expert Opin Investig Drugs] 2025 Jul-Aug; Vol. 34 (7-8), pp. 571-589. <i>Date of Electronic Publication: </i>2025 Jul 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9434197 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213543784%22">13543784 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Investig Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40657944
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/13543784.2025.2532446
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 571
    Titles:
      – TitleFull: Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Richardson PG
      – PersonEntity:
          Name:
            NameFull: O'Donnell EK
      – PersonEntity:
          Name:
            NameFull: O'Gorman P
      – PersonEntity:
          Name:
            NameFull: Leypoldt LB
      – PersonEntity:
          Name:
            NameFull: Laubach J
      – PersonEntity:
          Name:
            NameFull: Gay F
      – PersonEntity:
          Name:
            NameFull: Leleu X
      – PersonEntity:
          Name:
            NameFull: Facon T
      – PersonEntity:
          Name:
            NameFull: Moreau P
      – PersonEntity:
          Name:
            NameFull: Dimopoulos MA
      – PersonEntity:
          Name:
            NameFull: Goldschmidt H
      – PersonEntity:
          Name:
            NameFull: Mai EK
      – PersonEntity:
          Name:
            NameFull: Cavo M
      – PersonEntity:
          Name:
            NameFull: Weisel KC
      – PersonEntity:
          Name:
            NameFull: Berdeja JG
      – PersonEntity:
          Name:
            NameFull: Orlowski RZ
      – PersonEntity:
          Name:
            NameFull: Beksaç M
      – PersonEntity:
          Name:
            NameFull: Perrot A
      – PersonEntity:
          Name:
            NameFull: Mikhael J
      – PersonEntity:
          Name:
            NameFull: Martin T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul-Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1744-7658
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 7-8
          Titles:
            – TitleFull: Expert opinion on investigational drugs
              Type: main
ResultId 1